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Abstract
Background: Difficult biliary cannulation in endoscopic retrograde cholangiopancreatography (ERCP) can result in
failure of common bile duct (CBD) stone removal and pancreatitis. The present study aimed to report the efficacy
and safety of limited precut sphincterotomy (PS) combined with endoscopic papillary balloon dilation (EPBD) for
CBD stone removal in patients with difficult biliary cannulation, and the complications associated with this
combined procedure.
Methods: A total of 3305 patients underwent ERCP in our hospital between October 2009 and September
2014 and 258 were diagnosed with difficult biliary cannulation. Of these 258 patients, 58 underwent limited
PS combined with EPBD for CBD stone removal, and these 58 patients were included in this retrospective
study.
Results: The overall success rate was 94.8 % (55/58), and the success rate for single-session removal was 87.
9 % (51/58). The mean procedure time was 41 ± 11.48 min (range, 20–72 min). Mechanical lithotripsy was
needed in 10.3 % (6/58) of patients. Procedure-related complications included bleeding in 3.4 % (2/58), pancreatitis in
8.6 % (5/58) and biliary tract infection (BTI) in 1.7 % (1/58) of patients.
Conclusions: The therapeutic outcome of limited PS combined with EPBD for CBD stone removal in patients with
difficult biliary cannulation was good with an acceptable complication rate. It could be an alternative to PS and “early”
limited PS should be used for prompt identification of the bile duct. Limited PS combined with EPBD is safe and
effective for CBD stone removal in patients with difficult biliary cannulation.
Keywords: Precut sphincterotomy, Endoscopic sphincterotomy, Endoscopic papillary balloon dilation, Difficult biliary
cannulation, Common bile duct stones
Background
A common bile duct (CBD) stone complicated with chol-
angitis, obstructive jaundice, or pancreatitis is a common
disease of the biliary tract. Gaining access to the CBD is
the most importance step for successful therapeutic endo-
scopic retrograde cholangiopancreatography (ERCP) [1–7].
The cannulation success rate depends on patient selection,
the utilization of a specialized catheter, and the skill and
experience of the endoscopist [2, 7]. The overall success
rate of cannulation has been reported to be 90–95 % even
when performed by experts [1–5]. However, in 5–10 % of
cases, the CBD remains inaccessible, necessitating precut
sphincterotomy (PS) or fistulotomy (PF), percutaneous
transhepatic biliary drainage (PTBD), endoscopic ultra-
sound (EUS)-guided drainage, or surgery [1–7]. Difficult
biliary cannulation is defined as a situation in which an
endoscopist, using the regular cannulation technique, fails
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to cannulate the bile duct within a certain amount of time
or after a certain number of attempts [3, 6]. Some investi-
gators have proposed the definition of difficult biliary
cannulation as (1) failed cannulation within 10 min, (2) >5
pancreatic cannulation attempts, or (3) 5–10 attempts at
the papilla without a time limit [1–7]. Difficult biliary
cannulation leads to prolonged papillary manipulation
resulting in not only tissue edema but also repeated at-
tempts at cannulation or contrast injection of the pancre-
atic duct, and these factors have been reported to cause
post-ERCP pancreatitis in 4.3–11.3 % of cases [1, 3, 5, 6].
Needle-knife PS is the most commonly used procedures in
patients with difficult biliary cannulation, and it has been
reported to have success rates of 74.5–98.2 % [1–4, 6, 7].
However, PS is associated with post-ERCP complications
such as acute pancreatitis, duodenal bleeding and perfor-
ation, and is often regarded as a risky procedure, with com-
plication rates of 2–34 % [1–7]. Some published studies
have reported that sequential endoscopic papillary balloon
dilation (EPBD) after endoscopic sphincterotomy (EST)
is safe and effective for the management of CBD stones
and could decrease the occurrence of complications, in-
cluding procedure-related pancreatitis [8–13]. However,
reports on the efficacy of limited PS combined with
EPBD for CBD stone removal in patients with of difficult
biliary cannulation are scarce.
Therefore, the present study aimed to report the effi-
cacy and safety of limited PS combined with EPBD for
CBD stone removal in patients with difficult biliary




A total of 3305 patients underwent ERCP in our hospital
between October 2009 and September 2014 and 258
were diagnosed with difficult biliary cannulation. Of
these 258 patients, 58 of them had their index ERCP
with successful cannulations and underwent subsequent
limited PS combined with EPBD for CBD stone removal.
These 58 patients were analyzed in this retrospective
study. On the other hand, two hundred of these patients
encountered a first unsuccessful ERCP due to difficult
biliary cannulation and then decided not to have a
second one (none of them had received limited precut
procedure). One hundred and fifty-five of them chose to
receive surgery; 42 of them were treated by percutan-
eous biliary drainage and 3 received supportive
treatments.
The definition of difficult biliary cannulation in our
study was as follows: (1) failed cannulation within
10 min (2) 5 passages or injections of the pancreatic
duct, or (3) 10 attempts at the papilla without a time
limit (Fig. 1a). We stopped anticoagulant administration
such as aspirin for 7 days before the procedures in those
who were prescribed for primary prevention. For those
who received anticoagulant for secondary prevention in
low cardiovascular risk patients, we stopped clopidogrel,
Fig. 1 a Difficult biliary cannulation was due to failure of 10 attempts at duodenal papilla; (b) Limited precut sphincterotomy was performed
with the extent of cutting was less than half the length of the papillary mound; (c) Common bile duct stone was found after successful biliary
cannulation; (d) Endoscopic papillary balloon dilation was performed after limited precut sphincterotomy; (e and f) Common bile duct stone
was extracted by retrieval balloon
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prasugrel, ticagrelor and coumadin 5 days before ERCP
according to British Society of Gastroenterology and
European Society of Gastrointestinal endoscopy [14, 15].
For patients with high cardiovascular risks, the proce-
dures were postponed if possible until anticoagulant
could be discontinued safely (usually >12 months after
insertion of drug-eluting coronary stents or >1 month
after insertion of bare metal coronary stents). However,
when an emergent or semi-emergent indication like an
impacted stone or jaundice in need of immediate action
was encountered, cardiologists were routinely consulted
and replaced by other emergent non-endoscopic bilary
driange procedures. Prophylactic NSAIDs were given to
all patients to reduce risk of post-ERCP pancreatitis
routinely in our department.
The patients received pharyngeal anesthesia with
xylocaine spray in the same manner as that for general
endoscopy. Hyoscine-N-butylbromide (20 mg) was ad-
ministered intramuscularly before the procedure, and
meperidine (30 to 50 mg) was administered before
EPBD. ERCP was performed using a side-view endo-
scope (JF 260v and TJF 240; Olympus, Tokyo, Japan)
after selective cannulation of the CBD with a cholangi-
ography catheter (PR-113Q, Olympus). We preferred a
needle-knife sphincterotome (KD-V441, Olympus) in all
cases. Two highly experienced endoscopists [the first
and second authors], with experiences of more than
3000 ERCPs procedures each, and ongoing workloads of
more than 250 ERCPs procedures each annually, per-
formed all the limited PS combined with EPBD proce-
dures. Diathermy was applied with a blended current
(20 W cut and 20 W coagulation) using the ESG 100
system (Olympus). The incision started from the lip of
the papillary orifice (at the 11-o’clock position) and pro-
ceeded upward over the papillary mound. The extent of
cutting in limited PS is less than half the length of the
papillary mound (Fig. 1b). To perform EPBD after can-
nulation of the bile duct with limited PS (Fig. 1c), a
0.035-inch guide-wire (Zebra Exchange Guide-wire;
Microvasive Boston Scientific, Watertown, MA) was
inserted into the bile duct through the catheter. After
the guide-wire was inserted deeply into the bile duct, the
catheter was removed with the guide-wire left in place.
A balloon-tipped catheter (5.5 cm long and 8–20 mm
wide; Microvasive Boston Scientific), was inserted over
the guide-wire so that the balloon was extended across
the papilla. The balloon was inflated to 8–20 mm in
diameter with saline solution to dilate the papilla at pro-
gressively increasing pressures of 3 to 8 atm for 2 min,
according to the size of the CBD stones (Fig. 1d). After
removing the dilation catheter, stones were extracted
with a basket catheter or retrieval balloon (Fig. 1e, f ).
Endoscopic mechanical lithotripsy (EML) was used to
crush stones >15 mm in diameter when extraction of
these stones was difficult after EPBD. When stones were
not extracted completely, a biliary stent was inserted and
the residual stones were removed after 3–7 days without
repeating EPBD. A prophylactic pancreatic stent was not
used after EPBD. Complete stone removal was defined
as the absence of bile duct stones on a balloon occlusion
cholangiogram.
Definitions
A procedure-related complication was defined as any
adverse event related to the procedure, including pan-
creatitis, duodenal bleeding, perforation and biliary tract
infection. Acute pancreatitis was defined as abdominal
pain occurring within 24 h after the procedure in associ-
ation with high serum amylase and lipase levels equiva-
lent to at least 3 times the normal ranges and basal
levels on the day after ERCP [2]. Bleeding was defined as
any drop of over 15 % in the hemoglobin level, any clin-
ical sign of gastrointestinal bleeding (e.g., hematemesis
and tarry stool), or the need for blood transfusion [2].
Perforation was defined as the leakage of contrast
medium into the retroperitoneum or intraabdominal
cavity during ERCP or evidence of retroperitoneal-free
air on abdominal plain radiography or computer tomog-
raphy (CT) [2]. Biliary tract infection was defined as
presence of fever and/or chills, abdominal pain, jaundice,
and leukocytosis.
Results
This study included 58 patients (28 men and 30 women)
with CBD stones who underwent limited PS combined
with EPBD. The mean age of the patients was 64.02 years
(range, 26–96 years). The characteristics of the patients
are presented in Table 1. The procedure findings during
limited PS combined with EPBD are presented in Table 2.
Complete removal of CBD stones was achieved in 55 pa-
tients (94.8 %). Of these 55 patients, 51 patients (87.9 %)
required 1 session and 4 patients required 2 sessions for
complete removal (Table 2). The mean size of the CBD
stones was 1.11 ± 0.40 cm (range, 0.4–2.0 cm) and the
mean diameter of CBD was 1.47 ± 0.44 cm (range, 0.7–
2.6 cm). Of the 58 patients, 28 patients had one stone,
14 patients had 2 stones, and 16 patients had ≥3 stones.
Additionally, among the 58 patients, 41 patients had
distal CBD narrowing, 41 patients had jaundice, 28
patients had biliary tract infection (BTI), 19 patients had
duodenal periampullary diverticulum, and 13 patients
had impacted CBD stones. Removal was successful in
100 % (19/19) of patients with stones ≤1 cm and 92.3 %
(36/39) of patients with stones >1 cm (p = 0.544, Fisher’s
exact test). EML was used to crush stones >15 mm in
diameter when extraction of these stones was difficult
after EPBD in 6 patients (10.3 %). Removal failed in 3
patients because of large stones (1.5–2.0 cm) and CBD
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segmental strictures, and all the 3 patients underwent
surgery for removal of the CBD stones. Among the 58
patients, 2 patients (3.4 %) had procedure-related duo-
denal bleeding and were successfully treated with endo-
scopic epinephrine injection. None of the patients with
CAD, heart disease or stroke requiring anticoagulant
treatment; cirrhosis; or end-stage renal disease (ESRD)
had procedure-related duodenal bleeding or perfor-
ation. Among the 58 patients, 5 patients (8.6 %) had
procedure-related acute pancreatitis (mild pancrea-
titis). Of the 5 patients, 2 were men (7.1 % of the 28
men) and 3 were women (10 % of the 30 women),
and 2 of the 5 patients were under 60 years of age.
One patient (1.7 %) had procedure-related BTI, and
the pathogen was Escherichia coli. The overall com-
plication rate was 13.7 % (8/58). The mean follow-up
period was 29.0 ± 14.9 months (range, 1–60 months),
and no recurrence of symptomatic CBD stones was
noted during the follow-up period. The mean proced-
ure time of limited PS combined with EPBD was
41.0 ± 11.5 min (range, 20–72 min).
Discussion
Current study achieved a high success rate in CBD
stones removal of 94.8 % with a relative shorter mean
procedure time needed was 41.0 ± 11.5 min (range, 20–
72 min) in patients who underwent limited PS combined
with EPBD. Difficult biliary cannulation is one major
reason that influences the success rates and procedural
times used to remove bile duct stones during ERCP. It
is usually decided depending on the length of time,
number of selective biliary cannulation attempts, or the
number of unwanted pancreatic cannulations, or inser-
tion of a guide-wire into the pancreatic duct [2]. In
approximately 5–10 % of patients, biliary cannulation
cannot be achieved, and further complex techniques
are needed. Prolonged and repeated attempts of biliary
cannulation (more than 1 cannulation attempt or the
cannulation time was greater than 10 min) resulted in
extensive injury to the papilla and lead to post-ERCP
pancreatitis [16, 17].
The causes of difficult biliary cannulation are related
to anatomical and physiological factors, such as a
floppy papilla, small papillary orifice, cervical of the pa-
pilla, periampullary diverticulum, and surgically altered
anatomy, and improper positioning of the duodeno-
scope [3, 4, 18]. Additionally, pathological conditions,
such as stenosis of Oddi’s sphincter, duodenal inflam-
mation, ampullary and papillary neoplasms, large size
or number of stones, impacted stones, bile duct stric-
tures, and a relatively narrow distal CBD compared
with the stone size can cause difficult biliary cannula-
tion [3, 4, 19]. Distal CBD narrowing (41/58) was the
major cause of difficult biliary cannulation in our study,
and it may be related to chronic cholangitis. A duo-
denal periampullary diverticulum (19/58) and impacted
CBD stone (13/58) were also common causes of diffi-
cult biliary cannulation in our study.
The solutions for overcoming difficult biliary cannula-
tion in order to increase the success rate in CBD stones
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COPD and asthma 4
PS precut sphincterotomy, EPBD endoscopic papillary balloon dilation, CAD
coronary artery disease, COPD chronic obstructive pulmonary disease, ESRD
end-stage renal disease
Table 2 Procedure findings during limited PS combined with
EPBD
Procedure findings Number or size
Complete bile duct stone clearance 55
Number of sessions required to complete
bile duct stone clearance (1:2)
51:4
Successful removal of CBD stone
(≤1 cm : >1 cm)
19:36
Mean stone size (range) 1.11 ± 0.40 (0.4–2.0) cm
Stones size (≤1 cm : >1 cm) 19:39
Stone number (1:2: ≥3) 28:14:16
Mean CBD diameter (range) 1.47 ± 0.44 (0.7–2.6) cm
CBD diameter (≤0.8 cm : >0.8 cm) 4:54
Periampullary diverticulum 19
Distal CBD narrowing 41
Impacted CBD stone 13
Mechanical lithotripsy 6
Procedure time 41 ± 11.48 (20–72) min
PS precut sphincterotomy, EPBD endoscopic papillary balloon dilation, CBD
common bile duct
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removal and shortening the procedure time include
changing the catheter or operator, or applying a more
aggressive method, keeping in mind the increased risk of
complications [6]. The more aggressive methods include
needle-knife PS, papillary roof excision, transpancreatic
sphincterotomy, transpancreatic stenting, the double
wire technique, persistence, papillectomy, and the use of
a special knife [6]. If endoscopic methods fail, the transhe-
patic route can be used directly without an endoscopist or
the rendezvous technique can be applied, depending on
the cause of difficult biliary cannulation [6]. Needle-knife
PS is the most commonly used technique for difficult bil-
iary cannulation, and it has a success rate of 74.5–98.2 %
and complication rate has been reported to be 2–34 %
such as bleeding (2–9.5 %), pancreatitis (0.5–7.6 %) and
perforation (1.4–3 %) [1–4, 6, 7, 18, 20]. Some studies
have recommended the used of needle-knife PS in the
following situations: (1) stone impacting the papillary ori-
fice, (2) significant eminence of the ampulla or dilation at
the end of the CBD, (3) acute obstructive suppurative
cholangitis and pancreatitis due to biliary disorder, and (4)
Billroth II gastrectomy [7]. However, needle-knife PS is
contraindicated for a small flat papilla, periampullary di-
verticulum and malignant change of the papilla, because
the procedure can potentially make the cannulation
approach difficult or unsafe to perform [7]. The early ap-
plication of needle-knife PS for difficult biliary cannulation
has been reported to be time-saving, safe, and effective,
with no increase in the complication rate [1, 2, 4, 7]. Lim-
ited endoscopic sphincterotomy (EST) could minimize the
risk of complications that occur after complete EST such
as bleeding, bile reflux and biliary tract malignancy [8].
Among the 55 patients with successful CBD stone re-
moval, the success rate for single-session removal was
87.9 % (51/58) while the other four needed more than
once subsequent session removal of stones but were all re-
moved eventually(94.8 % overall). The therapeutic out-
come in the present study was as good as that reported
previously for patients without difficult biliary cannulation
who underwent EST or EPBD (79–100 %), or combination
therapy (80–100 %) with an acceptable complication rate
(13.7 %) [9–13, 18–25] with only mild procedure related
pancreatitis (8.6 %) and bleeding (3.4 %).
In the present study, no difference was noted in the
removal rate between CBD stones ≤1 cm (100 %, 19/19)
and those >1 cm (92.3 %, 36/39) (p = 0.554, Fisher’s exact
test). The proportion of patients who need EML to
crush stones when extraction of these stones was diffi-
cult after EPBD was 10.3 % in the present study. This
did not differ from the proportion of patients without
difficult biliary cannulation who underwent EST and
EPBD combination therapy and needed EML in previous
studies (0–33 %) [8–12, 23]. The procedure time for
CBD stone removal was longer in the present study
(mean, 41.0 ± 11.5 min; range, 20–72 min) than in
previous studies that reported patients without difficult
biliary cannulation (EST: mean, 21.9 ± 14.7 min; range,
3–63 min and EST combined with EPBD: mean, 13.1 ±
6.6 min; range, 4–35 min) [12]. The reason for the lon-
ger procedure time in the present study might be the
extra time required owing to difficult biliary cannulation.
There was no definite recurrence of symptomatic
CBD stones during the follow-up period (mean, 29.0 ±
14.9 months; range, 1–60 months) in our study.
The present study had some limitations. First, this was a
non-randomized retrospective study. Second, the sample
size was small for statistical analysis such as univariate
and multivariate analysis to evaluate clinical factors associ-
ated to the outcome. A larger sample size is needed to
further confirm the results of the present study.
Conclusions
The therapeutic outcome of limited PS combined with
EPBD for CBD stone removal in patients with difficult
biliary cannulation was good with an acceptable compli-
cation rate. It could be an alternative to PS and “early”
limited PS should be used for prompt identification of
the bile duct. Limited PS combined with EPBD is safe
and effective for CBD stone removal in patients with
difficult biliary cannulation.
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